Efficacy of temozolomide for recurrent embryonal brain tumors in children

Pharmacology, Toxicology and Pharmaceutical Science

• Temozolomide 100%
• Brain Tumor 100%
• Progression Free Survival 30%
• Neoplasm 30%
• Adverse Event 20%
• Chemotherapy 20%
• Atypical Teratoid Rhabdoid Tumor 20%
• Medulloblastoma 20%
• Tumor Growth 10%
• Nausea 10%
• Antiinfective Agent 10%
• Headache 10%
• Constipation 10%
• Neuroectoderm Tumor 10%
• Central Nervous System Tumor 10%
• Melanotic Neuroectodermal Tumor of Infancy 10%

Neuroscience

• Temozolomide 100%
• Brain Tumor 100%
• Magnetic Resonance Imaging 20%
• Adverse Effect 20%
• Medulloblastoma 20%
• Central Nervous System 10%
• Primitive Neuroectodermal Tumor 10%
• Headache 10%
• Radiation Therapy 10%